IPP Bureau

Lupin receives approval from TGA Australia for Tiotropium Dry Powder
Lupin receives approval from TGA Australia for Tiotropium Dry Powder

By IPP Bureau - July 26, 2023

Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule

NATCO files generic Erdafitinib Tablets in USA
NATCO files generic Erdafitinib Tablets in USA

By IPP Bureau - July 26, 2023

Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma

Jubilant Ingrevia consolidated Q1 FY2024 PAT up QoQ at Rs. 57.59 Cr
Jubilant Ingrevia consolidated Q1 FY2024 PAT up QoQ at Rs. 57.59 Cr

By IPP Bureau - July 26, 2023

Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023

AstraZeneca India receives permission from DCGI for Dapagliflozin
AstraZeneca India receives permission from DCGI for Dapagliflozin

By IPP Bureau - July 25, 2023

The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca

Need to strengthen food safety scientific standards: NITI Aayog
Need to strengthen food safety scientific standards: NITI Aayog

By IPP Bureau - July 24, 2023

There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits

Update on medical colleges in aspirational districts: PIB
Update on medical colleges in aspirational districts: PIB

By IPP Bureau - July 24, 2023

AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur

ABDM supports the integration of digital health infrastructure
ABDM supports the integration of digital health infrastructure

By IPP Bureau - July 24, 2023

Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations

13.91 crore teleconsultations have been completed:PIB
13.91 crore teleconsultations have been completed:PIB

By IPP Bureau - July 24, 2023

1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women

DGHS organizes National Webinar on National Organ and Tissue Transplant Organisation
DGHS organizes National Webinar on National Organ and Tissue Transplant Organisation

By IPP Bureau - July 24, 2023

Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar

Apollo performs 23000+ multi-organ transplantation
Apollo performs 23000+ multi-organ transplantation

By IPP Bureau - July 24, 2023

Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants

India brings traditional medicine at the forefront of India’s G20 presidency discourse: Amitabh Kant
India brings traditional medicine at the forefront of India’s G20 presidency discourse: Amitabh Kant

By IPP Bureau - July 24, 2023

Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts

Biocon Biologics gets EMA’s positive opinion for an ophthalmology product
Biocon Biologics gets EMA’s positive opinion for an ophthalmology product

By IPP Bureau - July 24, 2023

USFDA completes two cGMP inspections at Biocon Biologics' insulins facility in Malaysia
USFDA completes two cGMP inspections at Biocon Biologics' insulins facility in Malaysia

By IPP Bureau - July 24, 2023

The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories

Aurobindo Pharma gets 3 observations from USFDA for Unit 3 at Bachupally Village
Aurobindo Pharma gets 3 observations from USFDA for Unit 3 at Bachupally Village

By IPP Bureau - July 24, 2023

Aurobindo will respond to the US FDA within the stipulated timelines

Lupin receives tentative USFDA’s approval for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
Lupin receives tentative USFDA’s approval for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets

By IPP Bureau - July 24, 2023

This product would be manufactured at Lupin's Nagpur facility in India

Latest Stories

Interviews

Packaging